GlobeNewswire 9/3/2021 Progenity to Participate in Two Upcoming Investor Conferences
GlobeNewswire 8/24/2021 Progenity Announces Closing of $40 Million Underwritten Public Offering
GlobeNewswire 8/20/2021 Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants
GlobeNewswire 8/19/2021 Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
GlobeNewswire 8/12/2021 Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
GlobeNewswire 8/5/2021 Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
GlobeNewswire 8/4/2021 Neonatal Diagnostics Company InfanDx AG Appoints Dr. Gunter Weiss as COO
GlobeNewswire 7/29/2021 Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primar...
GlobeNewswire 6/30/2021 Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
GlobeNewswire 6/17/2021 Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
GlobeNewswire 6/15/2021 Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
GlobeNewswire 6/10/2021 Progenity Announces $40 Million Private Placement
GlobeNewswire 6/8/2021 Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
GlobeNewswire 6/2/2021 Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Ge...
GlobeNewswire 5/26/2021 Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
GlobeNewswire 5/25/2021 Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Rela...
GlobeNewswire 5/24/2021 Progenity Announces Poster Presentations at Digestive Disease Week 2021
GlobeNewswire 5/21/2021 Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Da...
GlobeNewswire 5/13/2021 Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results
GlobeNewswire 5/12/2021 Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
GlobeNewswire 5/11/2021 Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Deliv...
GlobeNewswire 5/6/2021 Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update
GlobeNewswire 5/5/2021 Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
GlobeNewswire 5/4/2021 Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
GlobeNewswire 4/30/2021 Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 202...